PFC
CLVS

Phocas Financial Corp’s Clovis Oncology, Inc. CLVS Stock Holding History

Phocas Financial Corp’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,200
Closed -$22K – 299
2018
Q4 		$22K Buy
+1,200
New +$24.5K ﹤0.01% 270

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Phocas Financial Corp's CLVS Position: Q1 2019 in Review

Phocas Financial Corp sold out of Clovis Oncology, Inc. (CLVS) in Q1 2019, closing a stake of 1,200 shares — an estimated $22K sold.

Phocas Financial Corp first reported a position in CLVS in Q4 2018 and held it in 1 quarter. The position peaked at $22K in Q4 2018. 186 funds tracked by Wall St. Rank hold CLVS as of Q1 2019.

  • Phocas Financial Corp reported no remaining Clovis Oncology, Inc. position as of Q1 2019 after selling out during the quarter.
  • Phocas Financial Corp sold 1,200 Clovis Oncology, Inc. shares in Q1 2019, an estimated $22K.
  • Phocas Financial Corp first reported a position in Clovis Oncology, Inc. in Q4 2018 and held it in 1 quarter.
  • Phocas Financial Corp's Clovis Oncology, Inc. position peaked at $22K in Q4 2018.
  • 186 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2019.

Based on Phocas Financial Corp's 13F filing for Q1 2019, filed 13 May 2019.